embecta is hosting a webinar titled Beneath the Surface, Recognizing and Preventing Lipohypertrophy on September 9 at 9:00 AM EDT featuring Dr. Julia Mader and Prof. Lutz Heinemann.
Published
Signal category
Presence & Recognition
Quote
“Join us for “Beneath the Surface, Recognizing and Preventing Lipohypertrophy” on September 9 at 9:00 AM EDT.”
— embecta team
Company
embecta
Advance every day together
- Industry
- Medical Device
- Location
- Parsippany, US
- Company size
- 1,167 employees
At embecta (formerly part of BD), we are singularly focused on improving the lives of people living with diabetes. With a 100-year legacy of developing and providing solutions to the diabetes community, today, we are a global medical technology company and leader in insulin delivery devices. More than 30 million people in over 100 countries rely on our pen needle and syringe products every day. BD is the manufacturer of the advertised products. Privacy Policy: https://www.embecta.com/en-us/about/policies/privacy-policy-statement
Founded 2022